Rechallenge With Cisplatin After an Acute Coronary Event

Key Result

Rechallenge with cisplatin can be safely performed in select patients after an acute coronary event with proper multidisciplinary evaluation.

Key Points

• The aim is to assess the safety of rechallenging patients with cisplatin after experiencing a myocardial infarction.
• Conducted a multidisciplinary evaluation of select patients
• Monitored for complications related to rechallenge with cisplatin
• Assessments included cardiac function and recovery status
• Rechallenge with cisplatin was performed safely in select patients
• No significant adverse events were observed during and after the process
• Prompt recognition of cisplatin-induced myocardial infarction was crucial for timely intervention